Call Us: (+39) 3476604994

Menu...

articoli e pubblicazioni

Abstract

  1. CASTELLANETA A, DI LEO A, DE TULLIO N, RENDINA M, FRANCIOSO D, FRANCAVILLA A. Estrogen Treatment Impairs Hepatic Dendritic Cell Function. Digestive and Liver Disease, March 2005; 37 (1): S36: OC2.3.3.
  2. CASTELLANETA A, DI LEO A, MARGIOTTA M, BARONE M, DE TULLIO N, AMORUSO AC, FRANCIOSO D, FRANCAVILLA A. Liver Regeneration, Dendritic Cells and Estrogen. Digestive and Liver   Disease, March 2005; 37 (1): S63: OC3.5.5.
  3. CASTELLANETA A, DI LEO A, MARGIOTTA M, BARONE M, DE TULLIO N, AMORUSO AC, FRANCIOSO D and FRANCAVILLA A. Estrogen receptor behaviour in liver dendritic cells during liver regeneration. Journal of Hepatology, April 2005; 42(2): 128: 344
  4. CASTELLANETA A, GAGLIARDI F, DE TULLIO N, AMORUSO AC, DI LEO A, FRANCAVILLA A. Impairment of T-cell stimulatory activity of liver and spleen dendritic cell in a murine model of hepatocarcinogenesis. Digestive and Liver Disease, April 2006; 38 (1): S3: CS2.1.
  5. CASTELLANETA A, DE TULLIO N, GAGLIARDI F, FRANCAVILLA R, DI LEO A, FRANCAVILLA A. Estrogen receptor expression in liver dendritic cells in respect to their different subpopulations and their maturation state. Digestive and Liver Disease, April 2006; 38 (1): S35: OC2.6.5.
  6. CASTELLANETA A, GAGLIARDI F, DE TULLIO N, AMORUSO A, DI LEO A, FRANCAVILLA A. Liver and spleen dendritic cell function modification in a murine model of hepatocarcinogenesis. Abstract book (p118) 48th Annual Meeting of the Italian Cancer Society (SIC). Bari, October 1-4, 2006.
  7. CASTELLANETA A, GAGLIARDI F, INTINI D, DE TULLIO N, AMORUSO A, DI LEO A, CAVALLO L, FRANCAVILLA A, FRANCAVILLA R. Characterisation of peripheral blood and resident intestinal dendritic cells in children with coeliac disease. Digestive and Liver Disease,October 2006; 38 (10): A87:CO1.
  8. CASTELLANETA A, DI LEO A, DE TULLIO A, GAGLIARDI F, AMORUSO AC, FRANCAVILLA A. T-cell stimulatory activity of liver and spleen dendritic cell during a model of hepatocarcinogenesis. Digestive and Liver Disease. 2007(39) A16
  9. CASTELLANETA A, DE TULLIO N, GAGLIARDI F, MARGIOTTA F, TANZI S, DEMARINIS L, DI LEO A, FRANCAVILLA A. Expression of estrogen receptor isoforms in liver dendritic cells. Digestive and Liver Disease. 2007(39) A16
  10. CASTELLANETA A, PRINCIPI M, DE TULLIO N, GAGLIERDI F, PISANI A, DI LEO A, FRANCAVILLA A . Peripheral blood dendritic cells enumeration in inflammatory bowel disease patients during infliximab treatment. Digestive and Liver Disease, September 2007;39(S2):S254:PA.155.
  11. CASTELLANETA A, GAGLIARDI F, DE TULLIO N, FRANCIOSO D, DI LEO A, FRANCAVILLA A. Relevant immunological changes associated with a murine model of hepatocarcinogenesis. . Digestive and Liver Disease, September 2007;39(S):S159:OC2.1.1
  12. CASTELLANETA A, GAGLIARDI F, DE TULLIO N, DI LEO A, FRANCAVILLA A . Modulation of cell proliferation activity of liver and spleen dendritic cells depending on different estrogen receptor isoforms expression. . Digestive and Liver Disease, September 2007;39(S2):S176:OC3.2.3
  13. PRINCIPI M, CASTELLANETA A, DE TULLIO N, GAGLIARDI F, RICCO A, CAZZATO L, PISANI A, DILEO A, DIMONTE D, FRANCAVILLA A. Granulocytapheresis (ADACOLUMN®) treatment in patients with ulcerative colitis in active phase. . Digestive and Liver Disease , March 2008;40(1):S138:PA.171
  14. BARONE M, MAIORANO E, TANZI S, LOFANO K, GUIDO R, DEMARINIS L, DE TULLIO N, PAPAGNI S, SCAVO M, COMELLI C, FRANCAVILLA A, DI LEO A. Effects of sylimarin and lignin administration on intestinal polyps development in a transgenic murine model for Apc gene (APC Min/+). Gut, Oct 2008;57:SII,A83.
  15. PRINCIPI M , DE TULLIO N, GUIDO R, PISANI A, FRANCAVILLA A, DI LEO A. E-worm and pillcam colon capsule: feasibility and patient acceptance. Digestive and Liver Disease, March 2009; 41(S): S38:OC.10.5
  16. BARONE M, TANZI S, LOFANO K, SCAVO M, PRICCI M, DEMARINIS L, PAPAGNI S, DE TULLIO N, GUIDO R, COMELLI MC, MAIORANO E, FRANCAVILLA A, DI LEO A. Dietary manipulations reduce adenomatous polyp development in intact male APCMin/+ mice by modulating intestinal estrogen receptor beta (ERbeta) expression. Digestive and Liver Disease, March 2009; 41(S):S177:P.116
  17. PRINCIPI, N. DE TULLIO, V. DEL PRETE, M. SCAVO, S. PAPAGNI, M.DILENA, R. LICINIO, A. DILEO. Estrogen receptor.beta expression as a molecular prognostic marker of cancer progression in ulcerative colitis. Inflammatory Bowel Disease 2010. PCC Prague Congress Centre; Czech Republic.
  18. PRINCIPI MB, GUIDO R, DE TULLIO N, PISANI A, ALBANO F, FRANCAVILLA A, DI LEO A. E-worm and pillcam colon capsule: feasibility and patient acceptance. DIGESTIVE DISEASE WEEK. T1608. MAY 1-5, 2010
  19. BARONE M, SCAVO MP, LICINIO R, DE TULLIO N, TANZI S, DI LEO A. Role of bone marrow stem cells in a model of intestinal carcinogenesis: APCmin/+ transgenic mice. Digestive and Liver Disease, March 2011; 43(3): S135:OC.08.2.
  20. PRINCIPI, N. DE TULLIO, M. SCAVO, A. MARZULLO, D. PISCITELLI, R. LICINIO, V. DEL PRETE, A.MADEO, F. ALBANO, A. DILEO. Molecular markers of cancer progression in AOM/DSS model for colitis-related colon carcinogenesis. Digestive and Liver Disease, March 2011; 43(3):S165:P.1.50
  21. PRINCIPI, N. DE TULLIO, K. LOFANO, M. PRICCI, MP. SCAVO, G. PIACENTINO, A. CONTALDO, V. NEVE, E. IERARDI, MC COMELLI, A. DI LEO. Effect of phytoestrogenic dietary supplementation on the progression of chronic intestinal inflammation to cancer in an animal model. Inflammatory Bowel Disease – 8thCongress of ECCO Vienna 2013; P085
  22. PRINCIPI, MP. SCAVO, D. PISCITELLI, V. VILLANACCI, A. CONTALDO, V. NEVE, K. LOFANO, G. PIACENTINO, N. DE TULLIO, E. IERARDI, A. DI LEO. The fall of estrogen receptor expression in long lasting ulcerative-associated carcinoma. Inflammatory Bowel Disease – 8thCongress of ECCO Vienna 2013; P013

 Articoli

  1. PRINCIPI, N. DE TULLIO, A. DI LEO. Adalimumab and perianal Crohn’s disease: case report. Digestive and Liver Disease , Supplements 4(2010):31-33.
  2. CASSANO, V. MASTRANDREA, M. PRINCIPI, F. LOCONSOLE, N. DE TULLIO, A. DILEO, G.A. VENA. Anti-Tumor Necrosis Factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease. Journal of Biological Regulators & Homeostatic Agents, 25(2)285-289.2011
  3. PRINCIPI, N. DE TULLIO, A. Di LEO. Caso clinico di paziente con colite ulcerosa cortico refrattario e intollerante all’ azatioprina. Adacolumn – Otsuka Casi Clinici 2011.
  4. PRINCIPI M , DE TULLIO N, SCAVO MP, PISCITELLI D, MARZULLO A, RUSSO S, ALBANO F, LOFANO K, PAPAGNI S, BARONE M, IERARDI & DI LEO A. Estrogen receptors expression in long-lasting ulcerative pancolitis with and without dyspasia: A preliminary report.Scand j Gastroenterol 2012 Oct;47(10):1253-4
  5. BARONE M, LOFANO K, DE TULLIO N, LICINO R, ALBANO F, DI LEO A. Dietary, Endocrine, and Metabolic Factors in the Development of Colorectal Cancer. J Gastrointest Cancer. 2012 mar; 43(1):30.
  6. BARONE M, ALTOMARE DF, ROTELLI MT, SCAVO MP, PISCITELLI D, DE TULLIO N, BOCALE D, DI LEO A. Disseminated tumour cells in bone marrow in experimental colon cancer: metastatic or resident? Colorectal Dis. 2013 Jun;15(6):667-73.
  7. PRINCIPI M, BARONE M, PRICCI M, DE TULLIO N, LOSURDO G, IERARDI E, DI LEO A. Ulcerative coliti: from inflammation to cancer. Do estrogen receptors have a role? World J Gastroenterol.2014 Sep 7;20(33):11496-504
  8. BRINGIOTTI R, IERARDI E, DE TULLIO N, FRACELLA MR, BRINDICCI D, MARMO R, ALBANO F, PAPAGNI S, DI LEO A, PRINCIPI M. Gastroenterology : Video capsule endoscopy disclosure of unprecedent therapeutic effect of Eviendep on small bowell polyposis syndrome. J Gastroenterol Hepatol. 2015 May ; 30(5):801
  9. BARONE M, SCAVO MP, LICINIO R, PIOMBINO M, DE TULLIO N, MALLAMACI R, DI LEO A. Role of Bone Marrow-Derived Stem Cells in Polyps Development in Mice with Apc (Min/+) Mutation. Stem Cells Int 2015 ;2015 :354.